Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 2;7(1):3.
doi: 10.3390/jcm7010003.

Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education

Affiliations
Review

Irritable Bowel Syndrome: Patient-Provider Interaction and Patient Education

Albena Halpert. J Clin Med. .

Abstract

The Patient-Provider (P-P) relationship is the foundation of medical practice. The quality of this relationship is essential, particularly for the management of chronic illness such as Irritable Bowel Syndrome (IBS), since it correlates with disease improvement. A significant aspect of fostering the P-P relationship is providing effective patient-centered education about IBS. An effective education empowers the patients to achieve the main therapeutic goals: to reduce symptoms and improve quality of life.

Method: A literature search of PubMed was conducted using the terms "Irritable Bowel syndrome", "Patient Physician Relationship", "Patient Provider Relationship", and "Patient Physician interaction". Preference was given to articles with a clearly defined methodology and those with control groups if applicable/appropriate. This article provides a review of the literature on Patient-Provider interaction and patient education as it relates to IBS and provides practical recommendations on how to optimize this important relationship.

Keywords: Irritable Bowel Syndrome (IBS); patient education; patient physician relationship; patient provider interaction; patient provider relationship.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

References

    1. Lucassen P., Olesen F. Context as a drug: Some consequences of placebo research for primary care. Scand. J. Prim. Health Care. 2016;34:428–433. doi: 10.1080/02813432.2016.1249065. - DOI - PMC - PubMed
    1. Lee H.F., Hsieh J.C., Lu C.L., Yeh T.C., Tu C.H., Cheng C.M., Niddam D.M., Lin H.C., Lee F.Y., Chang F.Y. Enhanced affect/cognition-related brain responses during visceral placebo analgesia in irritable bowel syndrome patients. Pain. 2012;153:1301–1310. doi: 10.1016/j.pain.2012.03.018. - DOI - PubMed
    1. Elsenbruch S., Kotsis V., Benson S., Rosenberger C., Reidick D., Schedlowski M., Bingel U., Theysohn N., Forsting M., Gizewski E.R. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: An fMRI study in healthy placebo responders and nonresponders. Pain. 2012;153:382–390. doi: 10.1016/j.pain.2011.10.036. - DOI - PubMed
    1. Chavarria V., Vian J., Pereira C., Data-Franco J., Fernandes B.S., Berk M., Dodd S. The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes. Clin. Ther. 2017;39:477–486. doi: 10.1016/j.clinthera.2017.01.031. - DOI - PubMed
    1. Elsenbruch S., Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat. Rev. Gastroenterol. Hepatol. 2015;12:472–485. doi: 10.1038/nrgastro.2015.117. - DOI - PubMed

LinkOut - more resources